Companies / Spero Therapeutics, Inc.
Spero Therapeutics, Inc.
Nasdaq: SPROCIK 1701108CAMBRIDGE, MA
Financials · FY2025
Ownership
58.2M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 3.48% | 2,026,051 |
| Institutions | 37.56% | 21,874,275 |
| Public float | 58.96% | 34,334,501 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Rajavelu EstherSee Remarks | 1.74% | 1,012,091 |
Keutzer TimothyChief Operating Officer | 1.28% | 742,506 |
Deshpande MilindDirector | 0.17% | 101,454 |
Pottage John C JrDirector | 0.15% | 85,000 |
Thomas Frank EDirector | 0.15% | 85,000 |
Institutional holders 58
View all →| Holder | Value | % of shares |
|---|---|---|
| $21.51M | 15.78% | |
| $5.50M | 4.06% | |
| $4.85M | 3.58% | |
| $2.78M | 2.04% | |
| $2.07M | 1.52% | |
| $1.97M | 1.53% | |
| $1.46M | 1.07% | |
| $1.31M | 1.02% | |
| $1.22M | 0.89% | |
| $927.0K | 0.68% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | Rajavelu Esther Executive | Sell | Common Stock | $119.9K | -51K -4.78% | 1,012,091 1.74% of shares | medium |
| Feb 6, 2026 | Rajavelu Esther Executive | Sell | Common Stock | $87.6K | -37K -3.37% | 1,062,907 1.83% of shares | low |
| Feb 3, 2026 | Keutzer Timothy Executive | Sell | Common Stock | $51.8K | -24K -3.07% | 764,629 1.31% of shares | low |
| Feb 6, 2026 | Keutzer Timothy Executive | Sell | Common Stock | $44.0K | -19K -2.45% | 742,506 1.28% of shares | low |
| Feb 2, 2026 | Keutzer Timothy Executive | Sell | Common Stock | $41.6K | -19K -2.34% | 788,853 1.35% of shares | low |
| Feb 2, 2026 | Rajavelu Esther Executive | Sell | Common Stock | $40.6K | -18K -1.65% | 1,100,008 1.89% of shares | low |
| Feb 4, 2026 | Keutzer Timothy Executive | Sell | Common Stock | $7.8K | -3K -0.45% | 761,158 1.31% of shares | low |
| Jun 23, 2026 | Deshpande Milind Director | Grant | Common Stock | $0 | +10K +10.93% | 101,454 0.17% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SPRO | Common Stock | 84833T103 |